The effects of NEAT1 knockdown and miR-129 overexpression, or along with CTBP2 upregulation, on ESCC cell viability and invasion were explored by CCK-8 and transwell invasion assays, respectively. The gene discussed is CTBP2; the disease is esophageal squamous cell carcinoma.